Covered recipient · General Payments record
SIRI GADDE
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2022–2024
$1,888.22
- Reported across 63 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $741.61 | 30 |
| Education | $90.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $185.44 | 7 |
| Penumbra, Inc. | $145.92 | 1 |
| Astellas Pharma US Inc | $138.36 | 3 |
| Novo Nordisk AS | $76.31 | 4 |
| Lilly USA, LLC | $57.96 | 4 |
| PFIZER INC. | $52.21 | 2 |
| ABBVIE INC. | $51.96 | 3 |
| Acerta Pharma LLC | $45.77 | 3 |
| Exact Sciences Corporation | $34.18 | 2 |
| Xeris Pharmaceuticals, Inc. | $23.06 | 1 |
| SHIELD THERAPEUTICS INC | $20.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.24 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103763516 | CMS |
| ABBVIE INC. | $15.94 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103763518 | CMS |
| ABBVIE INC. | $14.78 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103763520 | CMS |
| Amgen Inc. | $34.92 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115640708 | CMS |
| Amgen Inc. | $22.76 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117557847 | CMS |
| Amgen Inc. | $35.77 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115640716 | CMS |
| Amgen Inc. | $25.99 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117557849 | CMS |
| Amgen Inc. | $21.25 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117557851 | CMS |
| Amgen Inc. | $20.88 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117557853 | CMS |
| Amgen Inc. | $23.87 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117557855 | CMS |
| Astellas Pharma US Inc | $90.00 | 05/03/2024 | Education | Undisputed | 01/23/2026 | 1139348878 | CMS |
| Astellas Pharma US Inc | $28.43 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139359341 | CMS |
| Astellas Pharma US Inc | $19.93 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139353135 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.94 | 03/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105698154 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.16 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105640726 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.67 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105243099 | CMS |
| Exact Sciences Corporation | $15.93 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114665538 | CMS |
| Exact Sciences Corporation | $18.25 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114665542 | CMS |
| Lilly USA, LLC | $16.21 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135379936 | CMS |
| Lilly USA, LLC | $13.68 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135428688 | CMS |
| Lilly USA, LLC | $14.92 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135379938 | CMS |
| Lilly USA, LLC | $13.15 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135348971 | CMS |
| Novo Nordisk Inc | $18.32 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096810183 | CMS |
| Novo Nordisk Inc | $17.01 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096918034 | CMS |
| Novo Nordisk Inc | $18.26 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097146252 | CMS |
| Novo Nordisk Inc | $22.72 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097814164 | CMS |
| Penumbra, Inc. | $145.92 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1095782380 | CMS |
| PFIZER INC. | $29.50 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131906106 | CMS |
| PFIZER INC. | $22.71 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131946076 | CMS |
| SHIELD THERAPEUTICS INC | $20.44 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150126309 | CMS |
| Xeris Pharmaceuticals, Inc. | $23.06 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144613840 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.